Table 7
|
Reporting in guidelines of trials of antihypertensive medication a |
|||||||||||
| Triala |
Yearb |
CMA 1999 |
WHO 1999 |
VHA 1999 |
SIGN 2001 |
ESH 2003 |
ICSI 2003 |
JNC 2003 |
SA 2003 |
BHS 2004 |
NICE 2004 |
|
|
|||||||||||
| VA-II[48] |
1970 |
SR[49, 50] |
SR[49,51] |
SR[49,51,52] |
SR[51] |
SR[53] |
SR[51] |
SR[49] |
 |
||
| HSCSG[54] |
1974 |
SR[50] |
SR[51] |
SR[51] |
SR[51] |
SR[53] |
SR[51] |
|
|||
| USPHS[55] |
1977 |
SR[50] |
SR[51] |
SR[51] |
SR[51] |
SR[53] |
SR[51] |
|
|||
| VA-NHLBI[56] |
1978 |
SR[50] |
SR[51] |
SR[51] |
SR[51] |
SR[53] |
SR[51] |
|
|||
| HDFP[57-59] |
1979 |
SR[49] |
SR[49,51] |
SR[49,51,52,60] |
SR[51,61] |
|
|
SR[51] |
SR[49] |
|
|
| ANBPS[62] |
1980 |
SR[51] |
SR[51,52,60] |
SR[51,63] |
SR |
SR[51] |
|
||||
| EWPHE[64,65] |
1985 |
SR[49,50] |
SR[49,51,66] |
|
SR[51,61] |
SR[53] |
SR[51] |
SR[49] |
|
||
| IPPPSH[67] |
1985 |
|
|
|
|||||||
| MRC[68] |
1985 |
SR[50] |
|
SR[51] |
|
SR[53] |
SR[51] |
|
|||
| Coope[69] |
1986 |
SR[49] |
SR[49,51,66] |
|
SR[51,61] |
SR[53] |
SR[51] |
SR[49] |
|
||
| OSLO[70] |
1986 |
SR[50] |
SR[51] |
SR[51] |
SR[51] |
SR[53] |
SR[51] |
|
|||
| SHEP-P[71-73] |
1986 |
SR[50] |
SR[60] |
SR[61] |
SR[53] |
|
|||||
| HAPPHY[74] |
1987 |
SR[50] |
|
|
|||||||
| MAPHY[75] |
1988 |
|
|||||||||
| CAPPP[76,77] |
1990 |
|
|
|
|
|
|
||||
| SHEP[78-81] |
1991 |
|
|
|
|
|
|
|
|||
| STOP-H[82] |
1991 |
SR[49] |
|
|
SR[61] |
|
SR[53] |
SR[49] |
|
||
| SYST-EUR[83-86] |
1991 |
|
|
|
SR[87] |
|
|
|
|||
| MRC-O[88] |
1992 |
SR[50] |
|
|
SR[61] |
|
SR[53] |
SR[49] |
|
||
| STOP-H2[89-91] |
1993 |
SR[92] |
|
SR[63,87,93] |
|
|
|
||||
| NICS-EH[94,95] |
1994 |
SR[92] |
SR[63,87,93] |
SR[63,96] |
|
||||||
| HOT[97] |
1995 |
|
|
|
|
|
|
|
|
|
|
| PATS[98] |
1995 |
|
|
||||||||
| ALLHAT[99,100] |
1996 |
|
|
|
|
|
|||||
| MIDAS[101,102] |
1996 |
SR[50,92] |
|
|
SR[63] |
|
|||||
| VHAS[103] |
1997 |
SR[50,92] |
|
SR[3,87,93] |
SR[63,96] |
|
|||||
| ABCD[104] |
1998 |
SR[92] |
SR[87] |
|
|
|
|
||||
| FACET[105] |
1998 |
SR[92] |
|
||||||||
| UKPDS[106] |
1998 |
|
|
|
|
|
|
|
|
||
| HOPE[107] |
2000 |
|
|
|
|
|
|
|
|
||
| INSIGHT[108,109] |
2000 |
SR[92] |
|
|
|
||||||
| NORDIL[110] |
2000 |
SR[92] |
|
|
|
||||||
| IDNT[111] |
2001 |
SR[93] |
SR[96] |
|
|||||||
| PROGRESS[112] |
2001 |
c |
|
|
|
|
|
|
|||
| RENAAL[113] |
2001 |
|
|
||||||||
| ELSA[114] |
2002 |
|
SR[93] |
SR[96] |
|||||||
| LIFE[115] |
2002 |
|
|
|
|
||||||
| ANBP2[116,117] |
2003 |
SR[93] |
|
SR[96] |
|
||||||
| CONVINCE[118,119] |
2003 |
|
|
SR[96] |
|
||||||
| SCOPE[120] |
2003 |
|
SR[96] |
|
|||||||
| JMIC-B[121] |
2004 |
|
SR[96] |
||||||||
| VALUE[122-124] |
2004 |
|
|||||||||
|
a Trials post-dating the guidelines (indicated by the stepped line) were not available to the guideline developers. b Year of earliest publication. c Referred only to rationale and design.
SR Trial included in systematic review cited by guideline; primary report not cited by guideline. | |||||||||||
Campbell et al. BMC Health Services Research 2006 6:47 doi:10.1186/1472-6963-6-47 |
|||||||||||